Lokelma Launches in Korea for Hyperkalemia

AstraZeneca Korea launched Lokelma, a hyperkalemia treatment for CKD and heart failure patients. The drug enables continued RAAS inhibitor therapy, showing 88% normal potassium maintenance over 12 months.

Maternity Infrastructure Collapse in Daegu

Two pregnant women in Daegu were transferred to distant hospitals after local facilities refused admission due to shortage of obstetricians and neonatal care capacity, highlighting critical maternity infrastructure collapse.

Phase 1 Cancer Trials Evolution

Phase 1 cancer trials are evolving beyond safety testing to treatment strategy design. Combination therapies are now standard, requiring faster patient enrollment and strategic dose expansion to maintain global competitiveness.